Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Halaban

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Clinical Therapeutics|December 4, 2014
RAC1 and melanomaRuth Halaban
Oncology Research|August 31, 2002
Pigmentation in melanomas: changes manifesting underlying oncogenic and metabolic activitiesRuth Halaban
Pigment Cell & Melanoma Research|April 17, 2010
Meenhard HerlynRuth Halaban
Cancer Metastasis Reviews|June 30, 2005
Rb/E2F: a two-edged sword in the melanocytic systemRuth Halaban
The Journal of Investigative Dermatology|May 29, 2016
RASopathy Gene Mutations in MelanomaRuth Halaban, Michael Krauthammer
Melanoma Research|April 9, 2014
Rare SF3B1 R625 mutations in cutaneous melanomaYong Kong, Michael Krauthammer, Ruth Halaban
The Journal of Investigative Dermatology|August 23, 2002
Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutantsRuth Halaban, Elaine Cheng, Daniel N Hebert
Diagnostic Cytopathology|July 6, 2004
Novel tyramide-based tyrosinase assay for the detection of melanoma cells in cytological preparationsCesar Angeletti, Vitali Khomitch, Ruth Halaban, et al.
Journal of Cell Science|May 27, 2004
Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinaseSherri Svedine, Tao Wang, Ruth Halaban, et al.
The American Journal of Surgical Pathology|December 29, 2007
Metastatic peritoneal neurocutaneous melanocytosisMariana M Cajaiba, Denis Benjamin, Ruth Halaban, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Clinical Therapeutics|December 4, 2014
RAC1 and melanomaRuth Halaban
Oncology Research|August 31, 2002
Pigmentation in melanomas: changes manifesting underlying oncogenic and metabolic activitiesRuth Halaban
Pigment Cell & Melanoma Research|April 17, 2010
Meenhard HerlynRuth Halaban
Cancer Metastasis Reviews|June 30, 2005
Rb/E2F: a two-edged sword in the melanocytic systemRuth Halaban
The Journal of Investigative Dermatology|May 29, 2016
RASopathy Gene Mutations in MelanomaRuth Halaban, Michael Krauthammer
Melanoma Research|April 9, 2014
Rare SF3B1 R625 mutations in cutaneous melanomaYong Kong, Michael Krauthammer, Ruth Halaban
The Journal of Investigative Dermatology|August 23, 2002
Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutantsRuth Halaban, Elaine Cheng, Daniel N Hebert
Diagnostic Cytopathology|July 6, 2004
Novel tyramide-based tyrosinase assay for the detection of melanoma cells in cytological preparationsCesar Angeletti, Vitali Khomitch, Ruth Halaban, et al.
Journal of Cell Science|May 27, 2004
Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinaseSherri Svedine, Tao Wang, Ruth Halaban, et al.
The American Journal of Surgical Pathology|December 29, 2007
Metastatic peritoneal neurocutaneous melanocytosisMariana M Cajaiba, Denis Benjamin, Ruth Halaban, et al.
Pageof 9